Trevi Therapeutics, Inc. TRVI Finance Lease Principal Payments
Finance Lease Principal Payments at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.
The official record: Trevi Therapeutics, Inc.’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s finance lease principal payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s finance lease principal payments?
- Trevi Therapeutics, Inc. (TRVI) reported finance lease principal payments of $0 in Q4 2025.
- How has Trevi Therapeutics, Inc.'s finance lease principal payments changed year-over-year?
- Trevi Therapeutics, Inc.'s finance lease principal payments decreased by 100.0% year-over-year, from $31K to $0.
- What is the long-term trend for Trevi Therapeutics, Inc.'s finance lease principal payments?
- Over 2 years (2023 to 2025), Trevi Therapeutics, Inc.'s finance lease principal payments has grown at a -66.1% compound annual growth rate (CAGR), from $96K to $11K.
- What does finance lease principal payments mean?
- Represents the cash outflow for the reduction of the principal portion of outstanding finance lease obligations. This metric reflects the company's commitment to servicing long-term lease liabilities for assets used in operations. Monitoring this helps assess the company's fixed-obligation debt burden and cash flow management.